Three non-invasive treatment options of superficial basal cell carcinoma: Photodynamic therapy (PDT) [Metvix] vs imiquimod [Aldara] vs 5-fluorouracil [Efudix]: TTOP-sBCC trial.
Phase of Trial: Phase III
Latest Information Update: 21 May 2013
At a glance
- Drugs Imiquimod (Primary) ; Fluorouracil
- Indications Basal cell cancer
- Focus Therapeutic Use
- Acronyms TTOP-sBCC
- 14 May 2013 Results published in the Lancet Oncology.
- 17 Mar 2012 Additional lead trial centre identified as reported by EudraCT.
- 02 Mar 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.